文献速递肝胆胰外科围术期管理与 ERAS

高流量微创中心机器人辅助与腹腔镜左胰腺切除术比较

Robotic-assisted versus laparoscopic left pancreatectomy at a high-volume, minimally invasive center.
PubMed 文献 · Surg Endosc · 2018-11-12

该回顾性研究纳入247例微创左胰腺切除术(135例腹腔镜,108例机器人辅助),比较两者围手术期结局与费用。结果显示机器人组脾保留率更高、再入院率更高,腹腔镜手术更快且平均节省206.67美元手术室费用,两组临床显著B/C级胰瘘率约20%,肿瘤学结局与2年生存相似。

要点

  • 在高流量微创中心,腹腔镜与机器人左胰腺切除术均可有效实施。
  • 机器人组脾保留率更高,但再入院率也更高。
  • 腹腔镜手术时间更短,平均节省206.67美元手术室费用。

核心结论

  • 在高流量微创中心,腹腔镜与机器人左胰腺切除术在术者选择下同样有效。

研究设计与样本

  • 回顾性识别前瞻性REDCap数据库中的247例微创左胰腺切除术,其中腹腔镜135例、机器人辅助108例。
  • 另对胰腺导管腺癌亚组(腹腔镜35例、机器人23例)分析病理结局与2年生存。

主要发现

  • 两组术前人口学与手术指征无显著差异,34%因慢性胰腺炎、23%因胰腺导管腺癌手术。
  • 腹腔镜手术更快(p < 0.001),机器人组脾保留率更高(p < 0.001)。
  • 两组中位住院时间均为5天,临床显著B/C级胰瘘率均约20%。
  • 腹腔镜与机器人中转开腹率分别为4.3%与1.8%,机器人组再入院率更高(p = 0.035)。
  • 胰腺导管腺癌亚组病理结局与2年生存相似,腹腔镜平均节省206.67美元手术室费用。

临床怎么用

  • 在高流量微创中心,术者可依据技术偏好选择腹腔镜或机器人平台完成左胰腺切除术。

局限性

  • 回顾性设计,来自单中心高流量微创中心,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: While minimally invasive left pancreatectomy has become more widespread and generally accepted over the last decade, opinions on modality of minimally invasive approach (robotic or laparoscopic) remain mixed with few institutions performing a significant portion of both operative approaches simultaneously. METHODS: 247 minimally invasive left pancreatectomies were retrospectively identified in a prospectively maintained institutional REDCap™ database, 135 laparoscopic left pancreatectomy (LLP) and 108 robotic-assisted left pancreatectomy (RLP). Demographics, intraoperative variables, postoperative outcomes, and OR costs were compared between LLP and RLP with an additional subgroup analysis for procedures performed specifically for pancreatic adenocarcinoma (35 LLP and 23 RLP) focusing on pathologic outcomes and 2-year actuarial survival. RESULTS: There were no significant differences in preoperative demographics or indications between LLP and RLP with 34% performed for chronic pancreatitis and 23% performed for pancreatic adenocarcinoma. While laparoscopic cases were faster (p < 0.001) robotic cases had a higher rate of splenic preservation (p < 0.001). Median length of stay was 5 days for RLP and LLP, and rate of clinically significant grade B/C pancreatic fistula was approximately 20% for both groups. Conversion rates to laparotomy were 4.3% and 1.8% for LLP and RLP approaches respectively. RLP had a higher rate of readmission (p = 0.035). Pathologic outcomes and 2-year actuarial survival were similar between LLP and RLP. LLP on average saved $206.67 in OR costs over RLP. CONCLUSIONS: This study demonstrates that at a high-volume center with significant minimally invasive experience, both LLP and RLP can be equally effective when used at the discretion of the operating surgeon. We view the laparoscopic and robotic platforms as tools for the modern surgeon, and at our institution, given the technical success of both operative approaches, we will continue to encourage our surgeons to approach a difficult operation with their tool of choice.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Lyman WB, Passeri M, Sastry A, et al. Robotic-assisted versus laparoscopic left pancreatectomy at a high-volume, minimally invasive center. Surg Endosc. 2018. PMID: 30421076. doi:10.1007/s00464-018-6565-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。